ENSAT Stage I Adrenal Cortex Carcinoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which ENSAT Stage I Adrenal Cortex Carcinoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT03583710

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Canc…

This phase III trial studies how well mitotane alone works compared to mitotane with cisplatin and etoposide when given after surgery in treating patients with…

United States, France240 participantsStarted 2018-08-20

Treatment: Cisplatin, Etoposide

ENSAT Stage I Adrenal Cortex Carcinoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Canc…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Canc…

All recent trials (1 shown)